Iowa State Bank lessened its position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 5.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 47,373 shares of the company’s stock after selling 2,835 shares during the period. Cardinal Health comprises 1.4% of Iowa State Bank’s investment portfolio, making the stock its 19th biggest holding. Iowa State Bank’s holdings in Cardinal Health were worth $7,436,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in the business. Jones Financial Companies Lllp increased its stake in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the period. Atlantic Edge Private Wealth Management LLC lifted its holdings in shares of Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after buying an additional 75 shares during the period. Vermillion & White Wealth Management Group LLC grew its stake in shares of Cardinal Health by 55.0% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock worth $34,000 after purchasing an additional 71 shares during the period. NewSquare Capital LLC increased its holdings in Cardinal Health by 100.0% in the second quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock valued at $36,000 after buying an additional 107 shares in the last quarter. Finally, AlphaCore Capital LLC purchased a new position in Cardinal Health in the 2nd quarter valued at approximately $41,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.
Analysts Set New Price Targets
CAH has been the subject of several research reports. Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Citigroup boosted their target price on Cardinal Health from $165.00 to $190.00 and gave the stock a “neutral” rating in a report on Friday, October 31st. Deutsche Bank Aktiengesellschaft increased their price target on Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a report on Tuesday, November 18th. Robert W. Baird set a $232.00 price objective on shares of Cardinal Health in a research note on Friday, October 31st. Finally, Evercore ISI increased their price target on Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a report on Friday, October 31st. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $209.00.
Cardinal Health Trading Up 0.9%
Cardinal Health stock opened at $200.03 on Tuesday. Cardinal Health, Inc. has a 52 week low of $114.60 and a 52 week high of $214.93. The stock has a market cap of $47.53 billion, a price-to-earnings ratio of 30.17, a PEG ratio of 1.44 and a beta of 0.63. The company’s 50-day moving average price is $187.66 and its two-hundred day moving average price is $167.12.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating the consensus estimate of $2.22 by $0.33. The company had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The business’s revenue for the quarter was up 22.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More
- Five stocks we like better than Cardinal Health
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Pfizer Adds to Its Big Bet on Weight Loss Drugs
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- ServiceNow’s $7 Billion Gamble: Panic or Opportunity?
- The Risks of Owning Bonds
- Dell and HP Are Raising Prices—And Investors Should Take Note
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
